• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Glob Pediatr Health . The "Golden Hours" Algorithm For the Management of the Multisystem Inflammatory Syndrome in Children (MIS-C)

tetano

Editor, Senior Moderator
Glob Pediatr Health


. 2021 Jan 27;8:2333794X21990339.
doi: 10.1177/2333794X21990339. eCollection 2021.
The "Golden Hours" Algorithm For the Management of the Multisystem Inflammatory Syndrome in Children (MIS-C)


Sanaa Mahmoud[SUP] 1 2 3 [/SUP], Eman M Fouda[SUP] 2 3 [/SUP], Alyaa Kotby[SUP] 2 3 [/SUP], Hanan M Ibrahim[SUP] 2 3 [/SUP], Mervat Gamal[SUP] 2 [/SUP], Yasmin G El Gendy[SUP] 2 [/SUP], Eman Ahmed Zaky[SUP] 2 [/SUP], Nermine H Amr[SUP] 2 [/SUP], Dalia H El-Ghoneimy[SUP] 2 3 [/SUP], Asmaa Aa Alsharkawy[SUP] 2 [/SUP], Ashraf Omar[SUP] 2 [/SUP], Mahmoud El-Meteini[SUP] 2 [/SUP], Mostafa Elhodhod[SUP] 2 3 [/SUP]



Affiliations

Abstract

The global concern of increasing number of children presenting with multisystem inflammatory syndrome in children (MIS-C) related to the coronavirus disease (COVID-19) has escalated the need for a case-oriented clinical approach that provides timely diagnosis and management. The aim of this study is to share our experience in managing 64 MIS-C patients of North African ethnicity guided by a risk-based algorithm. Sixty-four patients met the inclusion criteria, 19 (30%) patients were categorized as mild and moderate risk groups and cared for in an isolation ward and 45 patients who belonged to the high-risk group (70%) were admitted to the pediatric intensive care unit (PICU). Positive laboratory evidence of COVID-19 was found in 62 patients. Fever and dysfunction in 2 or more organs were confirmed in all cases (100%). Fifty patients (78%) presented with gastrointestinal symptoms, meanwhile only 10 patients (16%) had respiratory manifestations. Cardiac involvement was reported in 55 (86%) cases; hypotension and shock were found in 45 patients (70%) therein circulatory support and mechanical ventilations were needed for 45 and 13 patients respectively. Intravenous immunoglobulins (IVIG) were used for all cases and methylprednisolone was used in 60 patients (94%). Fifty-eight (91%) patients were discharged home after an average of 9 days of hospitalization. The mortality rate was 9% (6 patients). Conclusion. A single Egyptian center experience in the management of MIS-C patients guided by a proposed bed side algorithm is described. The algorithm proved to be a helpful tool for first-line responders, and helped initiate early treatment with IVIG.

Keywords: COVID-19; IVIG; Kawasaki disease; algorithm; pediatric MIS-C.
 
Back
Top Bottom